LOX and neoplasm: In addition, epigenetic activation of LOX via lncRNA/miR-29c has also been demonstrated to facilitate M2 macrophage polarization and tumor immune escape, finally rendering tumor cells resistant to chemotherapeutic drugs in gastric cancer (Nai et al., 2021).